Sarepta Therapeutics Inc (SRPT) — Capital Reinvestment Ratio
Sarepta Therapeutics Inc (SRPT) has a Capital Reinvestment Ratio of 0.04x as of December 2025, meaning it reinvests 0% of its operating cash flow ($131.21 Million) in capital expenditures ($5.83 Million). Check SRPT intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Sarepta Therapeutics Inc Capital Reinvestment Ratio (2020–2020)
This chart tracks Sarepta Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see SRPT cash flow conversion.
Annual Capital Reinvestment Ratio for Sarepta Therapeutics Inc (2020–2020)
Year-by-year Capital Reinvestment Ratio for Sarepta Therapeutics Inc from 2020 to 2020. See Sarepta Therapeutics Inc (SRPT) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.76x | $107.47 Million | $82.20 Million | — |